OVIT (OncoVista Innovative Therapies) ROIC %: -58.99% (As of Sep. 2015)


What is OncoVista Innovative Therapies ROIC %?

OncoVista Innovative Therapies OVIT ROIC % is -58.99% as of Sep. 2015.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. OncoVista Innovative Therapies's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2015 was -58.99%.

As of today (2026-06-27), OncoVista Innovative Therapies's WACC % is 0.00%. OncoVista Innovative Therapies's ROIC % is 0.00% (calculated using TTM income statement data). OncoVista Innovative Therapies earns returns that do not match up to its cost of capital. It will destroy value as it grows.

OncoVista Innovative Therapies  (OTCPK:OVIT) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, OncoVista Innovative Therapies's WACC % is 0.00%. OncoVista Innovative Therapies's ROIC % is 0.00% (calculated using TTM income statement data). OncoVista Innovative Therapies earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

OncoVista Innovative Therapies ROIC % Related Terms

OncoVista Innovative Therapies ROIC % Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies ROIC % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -54.09 -297.23 -428.32 -285.29 -201.11

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.81 -422.65 -63.01 -222.84 -58.99

OVIT vs RSPI, HSTC, CAPS: ROIC % Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's ROIC % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's ROIC % falls into.


OncoVista Innovative Therapies ROIC % Calculation

OncoVista Innovative Therapies's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2014 is calculated as:

ROIC % (A: Dec. 2014 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2013 ) + Invested Capital (A: Dec. 2014 ))/ count )
=-2.546 * ( 1 - 0% )/( (0.916 + 1.616)/ 2 )
=-2.546/1.266
=-201.11 %

where

Invested Capital(A: Dec. 2013 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.096 - 2.3 - ( 0.045 - max(0, 3.216 - 0.096+0.045))
=0.916

Invested Capital(A: Dec. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.013 - 3.36 - ( 0.013 - max(0, 4.976 - 0.013+0.013))
=1.616

OncoVista Innovative Therapies's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2015 is calculated as:

ROIC % (Q: Sep. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2015 ) + Invested Capital (Q: Sep. 2015 ))/ count )
=-1.268 * ( 1 - 0% )/( (2.056 + 2.243)/ 2 )
=-1.268/2.1495
=-58.99 %

where

Invested Capital(Q: Jun. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.028 - 4.309 - ( 0.028 - max(0, 6.365 - 0.028+0.028))
=2.056

Invested Capital(Q: Sep. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.061 - 3.708 - ( 0.061 - max(0, 5.951 - 0.061+0.061))
=2.243

Note: The Operating Income data used here is four times the quarterly (Sep. 2015) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -58.99% mean?
OncoVista Innovative Therapies (OVIT) has a ROIC % of -58.99% as of Sep. 2015. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' ROIC % too high?
OncoVista Innovative Therapies' current ROIC % is -58.99%.
How does OncoVista Innovative Therapies' ROIC % compare to RSPI and HSTC?
OncoVista Innovative Therapies' ROIC % of -58.99% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current ROIC % is -58.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current ROIC % of -58.99%. The current ROIC % is -58.99%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current ROIC % is -58.99% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.